Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × Neoadjuvant Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Sarcoma 3 Rectal Neoplasms 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Kidney Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Intraductal, Noninfiltrating 2 Vomiting 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostate Adenocarcinoma 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡